Related references
Note: Only part of the references are listed.Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Xiang Zhang et al.
JOURNAL OF CANCER (2020)
The Role of Autophagy in Pancreatic Cancer-Recent Advances
Maria New et al.
BIOLOGY-BASEL (2020)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Xiaomeng Liu et al.
MOLECULAR CANCER (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response
Vrishketan Sethi et al.
GASTROENTEROLOGY (2018)
Effectiveness of Multi-strain Versus Single-strain Probiotics Current Status and Recommendations for the Future
Arthur C. Ouwehand et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
A Believer's Overview of Cancer Immunosurveillance and Immunotherapy
Olivera J. Finn
JOURNAL OF IMMUNOLOGY (2018)
Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders
D. Pagliari et al.
MEDIATORS OF INFLAMMATION (2018)
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
Kei Takahashi et al.
ONCOGENE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Probiotics in Disease Prevention and Treatment
Yuying Liu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Efficacy of Lactobacillus Administration in School-Age Children with Asthma: A Randomized, Placebo-Controlled Trial
Chian-Feng Huang et al.
NUTRIENTS (2018)
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients
Stefania Canova et al.
TUMORI (2017)
A review of dose-responses of probiotics in human studies
A. C. Ouwehand
BENEFICIAL MICROBES (2017)
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients
Stefania Canova et al.
TUMORI (2017)
Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice
Bor-Show Tzang et al.
BRITISH JOURNAL OF NUTRITION (2017)
Dual role of inflammatory mediators in cancer
T. G. Shrihari
ECANCERMEDICALSCIENCE (2017)
The Potential Role of Probiotics in Cancer Prevention and Treatment
Ai-Qun Yu et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2016)
Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma
Vanaja Konduri et al.
ONCOIMMUNOLOGY (2016)
Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer
Freya A. Goumas et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
Rushika M. Perera et al.
CANCER DISCOVERY (2015)
The immune network in pancreatic cancer development and progression
S. M. Woermann et al.
ONCOGENE (2014)
Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials
Shanmiao Gou et al.
CRITICAL CARE (2014)
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
Michele T. Yip-Schneider et al.
BMC CANCER (2013)
Lactobacillus paracasei Comparative Genomics: Towards Species Pan-Genome Definition and Exploitation of Diversity
Tamara Smokvina et al.
PLOS ONE (2013)
Chronic inflammation in cancer development
Gabriele Multhoff et al.
FRONTIERS IN IMMUNOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Precursor lesions in pancreatic cancer: morphological and molecular pathology
Christopher J. Scarlett et al.
PATHOLOGY (2011)
Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations
Hideaki Ijichi
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
In vitro binding of mutagenic heterocyclic aromatic amines by Bifidobacterium pseudocatenulatum G4
F. Faridnia et al.
BENEFICIAL MICROBES (2010)
Oral administration of gemcitabine in patients with refractory tumors: A clinical and pharmacologic study
Stephan A. Veltkamp et al.
CLINICAL CANCER RESEARCH (2008)
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations
RH Hruban et al.
CANCER RESEARCH (2006)
Dietary intake of heterocyclic amines and benzo(a)pyrene: Associations with pancreatic cancer
KE Anderson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains
M Zsivkovits et al.
CARCINOGENESIS (2003)
Share Paper
